New Science Ventures, based in New York, backs specialist life sciences, deep tech, and enterprise software startups from Pre-Seed to Series B, and can lead rounds, as with Paragraf and biomodal.
3 people on the investing team, 3 of them partners who can make the call. Partners are listed first.



Work here and something is wrong? Ask for a correction.


Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckOne email when this firm shows new activity. Nothing else.
New Science Ventures reports entry at pre-seed, seed, series a, series b.
New Science Ventures has not reported a check size.
Yes. New Science Ventures says it can lead.
Somu Subramaniam (Managing Partner), Andrew Abrams (Partner), Tom Lavin (Partner).
No recent activity since September 2026.
Work at New Science Ventures? Claim or correct this profile.